摘要:目的:观察厄贝沙坦治疗非杓型高血压患者降压效果及其杓型血压昼夜节律恢复情况,并观察治疗后血浆醛固酮水平的影响。方法:对杓型和非杓型两组原发性高血压患者分别给予150300 mg/d,观察降压效果及对血压昼夜节律的影响,并监测用药前后血浆醛固酮水平的变化。结果:所有高血压患者应用厄贝沙坦治疗前后收缩压及舒张压均有不同程度的下降,非杓型组夜间收缩压及舒张压的下降值与杓型相比有统计学差异,出现了明显的昼夜节律,血浆醛固酮水平出现了明显差异。结论:厄贝沙坦对非杓型高血压患者有良好的降压作用,并能恢复非杓型高血压患者的昼夜节律,向杓型血压变化。Abstract: Objective: To investigate the effect of blood pressure control and circadian variability of dipper blood pressure induced by irbesartan in patients with nondipper essential hypertension and to observe levels of aldosterone.after treatment.Methods:The patients were divided into dipper and nondipper groups. All patients were treated with irbesartan (150300 mg/d). The variability of circadian blood pressure were observed, and the levels of plasma aldosterone were monitored before and after treatment Results: After the treatment with irbesartan, the blood pressure in all patients were evidently reduced. The night blood pressure of the patient with nondipper essential hypertension had more significant improvement . The circadian variability was appeared. The levels of aldosterone had a significant difference between day and night. Conclusion:Irbesartan has significant effects for the patients with nondipper essential hypertension. It can induce a circadian variability and recover the dipper blood pressure from nondipper blood pressure.
Abstract: Objective To investigate the effect of intramyocardial injection of slow release microspheres of tannic acid (TA) on ventricular remodeling after acute myocardial infarction (AMI) in rats. Methods Slow release microspheres of TA were prepared and the release parameters in vitro were detected. AMI model in rats was induced. Eighty rats were enrolled and divided into 4 groups by random digital table:poly (lactic-co-glycolic acid) (PLGA) microspheres injection (PLGA group, n=24), PLGA-TA microspheres injection (PLGA-TA group, n=24), TA injection group (TA group, n=16) and normal saline injection group (NS group, n=16). Heart function was evaluated by echocardiography after the injection. The structure of cardiac extracellular matrix (ECM) in the infarcted borderline area was evaluated at 4th week after the injection. Collagen content in the infarcted area was evaluated by hydroxyproline colorimetry assay at 2nd and 4th week after the injection. Results TA release was maintained at a constant rate from the microspheres for one month in vitro. Two weeks after the injection, left ventricular ejection fraction(LVEF), left ventricular fraction shortening(LVFS), left ventricular end-diastolic diameter(LVEDD) and left ventricular end-systolic diameter(LVESD) in PLGA-TA group and TA group were significantly better than those in the other two groups(P<0.05). Four weeks after the injection, LVEF, LVFS, LVEDD and LVESD in PLGA-TA group were significantly better than those in the other three groups (P<0.05). Four weeks after the injection, slow release microspheres of TA in the PLGA-TA group effectively improved the arrangement of ECM compared with TA group. Four weeks after the injection, collagen content in the infarcted area of PLGA-TA group was significantly higher than that in TA group(88.88±7.28 μg/mg dry weight vs. 72.43±9.02 μg/mg dry weight), PLGA group(88.88±7.28 μg/mg drg weight vs. 71.97±6.06 μg/mg dry weight) and NS group(88.88±7.28 μg/mg dry weight vs. 68.86±7.55 μg/mg dry weight, F=7.162,P=0.003), but there was no statistical difference in the collagen content of the infarcted area among TA group, PLGA group and NS group (P>0.05) . Conclusion Intramyocardial injection of slow release microspheres of TA can maintain a constant release of TA for a comparatively long period, inhibit collagen matrix degradation, and effectively attenuate ventricular remodeling after AMI in rats.